(Press-News.org) SALT LAKE CITY—A new study of the genetic makeup, or genome, of Ewing sarcoma, a rare cancer that strikes children, teenagers, and young adults, has produced multiple discoveries: a previously unknown sarcoma subtype, genetic factors related to long-term survival, and identification of a genetic change between the primary and metastatic stages of the disease that could lead to better, more targeted treatment.
Researchers from Huntsman Cancer Institute (HCI) at the University of Utah used a new, advanced technology called molecular inversion probes (MIPs) to analyze DNA changes in the genome of Ewing sarcoma tumors. The report appears today in the online issue of the journal Cancer Genetics.
New Subtype of Ewing Sarcoma
According to the study's principal investigator, Joshua Schiffman, M.D., associate professor of pediatrics at the University of Utah and an HCI investigator, up to 10 percent of the tumor samples revealed that DNA in a specific region of the genome was missing, including a gene called SMARCB1. The same deletion had been described before in another aggressive and deadly sarcoma called a rhabdoid tumor. Pathologists double-checked the diagnosis on these samples and determined that they were not misdiagnosed rhabdoid tumors, but were indeed Ewing sarcoma that also had this rhabdoid characteristic.
"Discovering this new subset of Ewing sarcoma is especially important because the patients with this deletion were among the long-term survivors," said Schiffman. "It opens up questions about the biology of this tumor and whether patients with this type of cancer need different treatment."
Genome Factors Correlate with Long-Term Survival
The researchers also looked at the relationship between the Ewing sarcoma genome and patient outcomes and found factors in eight areas of the genome correlated in varying degrees with long-term survival after diagnosis. They compared the samples that contained none of these factors to those with one or more. Outcomes for the patients with none of the factors were considerably better: 80 percent of them had no recurrence of the disease after initial treatment, and even more outstanding, 100 percent survived more than 12 years after diagnosis. For patients with one or more of the factors, only about 40 percent survived that long.
"Our results will have to be validated with a larger number of samples, but MIPs give us the tool to do that on clinically archived samples," said Schiffman. "Clearly, learning more about cancers with these genomic factors will be essential to finding new treatments that will improve overall survival among all Ewing sarcoma patients."
Gene Difference in Metastatic Ewing Sarcoma Cells
The current model for how cancer spreads, or metastasizes, in the body holds that primary tumors change in some way that allows the cancer cells to spin off and move to other parts of the body. The researchers compared the DNA differences between primary tumor (the initial location of the cancer) cells, metastasized cells, and normal cells in the same patients.
"We found a specific gene that was present only in the metastatic tumors and not the primary tumor or normal cells," said Schiffman. "That gene has been described before in relation to other types of cancers, but not Ewing sarcoma.
"People don't die from a primary tumor," he added. "It's cancer metastasizing and spreading through the body that kills. As we learn what makes tumors metastatic, we can search for treatments that may keep primary tumors from making that change or target this specific change once it already has occurred in metastatic tumors."
Use of Archived Tumor Samples
Only 300 to 400 new Ewing sarcoma cases are diagnosed per year in the United States. "The rarity of Ewing sarcoma poses a problem for cancer research," said Schiffman. "Because there are so few cases, it has been difficult in the past to find enough tissue samples to conduct valid studies of the genetics and biology of this disease."
Unlike other genetic analysis techniques, MIPs give very high quality, genome-wide, high-resolution DNA analysis for clinical samples that have been preserved in formalin and encased in paraffin wax blocks, a process called FFPE. "FFPE has been the standard technique for preserving pathology samples for decades," said Schiffman. "But until recently, genomics technology has not been available to make use of the huge resource these samples represent."
"We analyzed FFPE samples of primary tumors from Ewing sarcoma patients at Primary Children's Medical Center in Salt Lake City from the past 12 years. This doesn't sound like a large sample, but for this rare cancer it reflects 10 percent of all cases diagnosed in a given year, so the quantity is significant," he added.
### A review article by Schiffman on research using the MIP technique will accompany the research report in the same issue of Cancer Genetics. Several HCI investigators collaborated on this research, including R. Lor Randall, M.D., F.A.C.S.; Kevin B. Jones, M.D.; Stephen L. Lessnick, M.D., Ph.D.; and Ken Boucher, Ph.D.
The research was supported by funding from St. Baldrick's Foundation, a Sarcoma Alliance for Research through Collaboration (SARC) Career Development Award, a Damon Runyon Clinical Investigator Award, and the Eunice Kennedy Shriver Children's Health Research Career Development Award NICHD 5K12HD001410. The National Institutes of Health support Huntsman Cancer Institute through P30 CA042014.
The mission of Huntsman Cancer Institute (HCI) at the University of Utah is to understand cancer from its beginnings, to use that knowledge in the creation and improvement of cancer treatments, to relieve the suffering of cancer patients, and to provide education about cancer risk, prevention, and care. HCI is a National Cancer Institute-Designated Cancer Center, which means that it meets the highest national standards for cancer care and research and receives support for its scientific endeavors. HCI is also a member of the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of the world's leading cancer centers that is dedicated to improving the quality and effectiveness of care provided to patients with cancer. For more information about HCI, please visit www.huntsmancancer.org.
Genomic study of rare children's cancer yields possible prognostic tool
2012-08-09
ELSE PRESS RELEASES FROM THIS DATE:
NIST focuses on testing standards to support lab on a chip commercialization
2012-08-09
Lab on a chip (LOC) devices—microchip-size systems that can prepare and analyze tiny fluid samples with volumes ranging from a few microliters (millionth of a liter) to sub-nanoliters (less than a billionth of a liter)—are envisioned to one day revolutionize how laboratory tasks such as diagnosing diseases and investigating forensic evidence are performed. However, a recent paper* from the National Institute of Standards and Technology (NIST) argues that before LOC technology can be fully commercialized, testing standards need to be developed and implemented.
"A testing ...
Depression linked with increased risk of peripheral artery disease
2012-08-09
Depression was linked with an increased risk of peripheral artery disease (PAD) in a study of more than one thousand men and women with heart disease conducted by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
PAD is a circulatory problem in which narrowed arteries reduce blood flow to the limbs – usually the legs and feet – resulting in pain, reduced mobility and, in extreme cases, gangrene and amputation.
The study was published electronically on July 26, 2012, in the Journal of the American Heart Association.
Marlene ...
Scientists use worms to unearth cancer drug targets
2012-08-09
BETHESDA, MD – August 9, 2012 -- Through novel experiments involving small nematode worms, scientists from Wyoming have discovered several genes that may be potential targets for drug development in the ongoing war against cancer. Specifically, researchers hypothesize that inhibiting these genes could reverse certain key traits associated with cancer cells. This discovery is published in the August 2012 issue of the Genetics Society of America's journal GENETICS (www.genetics.org).
"Cancer is a leading cause of death worldwide," said David S. Fay, Ph.D., a researcher ...
New Genetics educational resource promotes active learning
2012-08-09
BETHESDA, MD – August 9, 2012 -- As upper level undergraduate genetics instructors plan their syllabi for the fall semester, the Genetics Society of America's GENETICS journal offers a new educational resource, articles called "Primers." These articles are designed to bring cutting-edge scientific research into the classroom by making scientific papers accessible to students.
The principal learning goal of the Primer is to "make research and genetics accessible to a much broader audience, not just researchers, their postdocs and grad students, but also to undergraduates ...
Genetics Society of America’s GENETICS journal highlights for August 2012
2012-08-09
Bethesda, MD—August 9, 2012 – Listed below are the selected highlights for the August 2012 issue of the Genetics Society of America's journal, GENETICS. The August issue is available online at www.genetics.org/content/current. Please credit GENETICS, Vol. 191, AUGUST 2012, Copyright © 2012.
Please feel free to forward to colleagues who may be interested in these articles.
ISSUE HIGHLIGHTS
New negative feedback regulators of Egfr signaling in Drosophila, pp. 1213
Jonathan P. Butchar, Donna Cain, Sathiya N. Manivannan, Andrea D. McCue, Liana Bonanno, Sarah Halula, ...
Scientists discover how iron levels and a faulty gene cause bowel cancer
2012-08-09
HIGH LEVELS of iron could raise the risk of bowel cancer by switching on a key pathway in people with faults in a critical anti-cancer gene, according to a study published in Cell Reports* today (Thursday).
Cancer Research UK scientists, based at the University of Birmingham and the Beatson Institute for Cancer Research in Glasgow, found bowel cancers were two to three times more likely to develop in mice with a faulty APC gene that were fed high amounts of iron compared to mice who still had a working APC gene.
In contrast, mice with a faulty APC gene fed a diet low ...
Urban poor plagued by 'burdens of place'
2012-08-09
EAST LANSING, Mich. — Most of America's urban cores were designed for walking but offer little in the way of supermarkets, healthy restaurants and other amenities for residents to walk to, according to a study led by a Michigan State University scholar.
The study is one of the first to show that poor residents living in declining urban neighborhoods want healthy food choices – evidenced by their willingness to travel long distances to find them. Past research has generally assumed that poor people will shop at whatever store is closest.
But compared with suburban residents, ...
Plenty of dark matter near the Sun
2012-08-09
Dark matter was first proposed by the Swiss astronomer Fritz Zwicky in the 1930s. He found that clusters of galaxies were filled with a mysterious dark matter that kept them from flying apart. At nearly the same time, Jan Oort in the Netherlands discovered that the density of matter near the Sun was nearly twice what could be explained by the presence of stars and gas alone. In the intervening decades, astronomers developed a theory of dark matter and structure formation that explains the properties of clusters and galaxies in the Universe, but the amount of dark matter ...
Looking to Lose Weight?
2012-08-09
SHREWSBURY, MA – A new study published in Nutrition Journal shows that people can lose weight while consuming typical amounts of sugar or high fructose corn syrup (HFCS) if their overall caloric intake is reduced.
"Our research debunks the vilification of high fructose corn syrup in the diet," said James M. Rippe, M.D., one of the study authors. "The results show that equally reduced-calorie diets caused similar weight loss regardless of the type or amount of added sugars. This lends further support to findings by our research group and others that table sugar and HFCS ...
89 million people medically uninsured during 2004 to 2007
2012-08-09
Eighty-nine million Americans were without health insurance for at least one month during the period from 2004 to 2007, and 23 million lost coverage more than once during that time, according to researchers at Penn State and Harvard University.
"These findings call attention to the continuing instability and insecurity of health insurance in our country," said Pamela Farley Short, professor of health policy and administration, Penn State. "With more than a third of all Americans under age 65 being uninsured at some point in a four-year period, it's easy to see that the ...